Chronic Fatigue Can Persist for 1 Year After a Ministroke

Translate to Spanish or other 102 languages!

Transient ischemic attacks may result in 1 year of chronic fatigue, a new study finds. Image for illustration purposes
Transient ischemic attacks may result in 1 year of chronic fatigue, a new study finds. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

  • Transient ischemic attacks occur when there is a temporary blockage to the brain’s blood supply. 
  • Research about the potential long-term impact of transient ischemic attacks is ongoing.
  • A recent study has found that people who experience a transient ischemic attack, or ‘ministroke,’ can experience fatigue for as long as a year afterwards. 

Transient ischemic attacksTrusted Source — sometimes referred to as “ministrokes” — involve a temporary blockage to the brain’s blood supply. People who experience a transient ischemic attack may go on to experience a stroke later on.

Follow the link below to Medical News today for the full story:

- Advertisement -

https://www.medicalnewstoday.com/articles/chronic-fatigue-can-persist-for-1-year-after-a-mini-stroke

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Massive FDA Study Confirms Most U.S. Infant Formulas Meet High Safety Standards

Mega Doctor News U.S. Department Health and Human Services The U.S. Food and...

Scientists Discover Immune-Linked Variant of Diabetic Kidney Disease

A detailed new map of the human kidney revealed a previously unrecognized form of diabetic kidney disease (DKD) marked by clusters of immune cells—specifically B cells—that are linked to faster disease progression.

The Best Way to Wash Every Type of Produce

With spring in full swing, plenty of fruits and vegetables are in season, but before you enjoy them at your next meal, it’s important to wash them first.

New Blood Test Detects Testicular Cancer Missed by Standard Markers

Mayo Clinic researchers have developed a blood-based method that may help detect germ cell tumors, the most common type of testicular cancer, including cases that do not show up on standard blood tests, according to a study published in Nature Communications.
- Advertisement -